Biocon’s Oral Insulin Gains Momentum With JDRF Backing

 
• By Anju Ghangurde
  
Diabetes
BIOCON's ORAL INSULIN PLAN IS BEING BACKED BY JDRF

More from Alimentary/Metabolic

More from Therapy Areas